Blockade of Activin Receptor IIB Protects Arthritis Pathogenesis by Non‐Amplification of Activin A‐ACVR2B‐NOX4 Axis Pathway

Although activin receptor IIB (ACVR2B) is emerging as a novel pathogenic receptor, its ligand and assembled components (or assembly) are totally unknown in the context of osteoarthritis (OA) pathogenesis. The present results suggest that upregulation of ACVR2B and its assembly could affect osteoarth...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Jimin, Lee, Hyemi, Jeon, Min‐Seung, Kim, Seok‐Jung, Choi, Cham, Kim, Ki Woo, Yang, Dong Joo, Lee, Sangho, Bae, Yong‐Soo, Choi, Won Il, Jung, Juyeon, Eyun, Seong‐il, Yang, Siyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190289/
https://www.ncbi.nlm.nih.gov/pubmed/36950748
http://dx.doi.org/10.1002/advs.202205161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190289/
https://www.ncbi.nlm.nih.gov/pubmed/36950748
http://dx.doi.org/10.1002/advs.202205161

Ejemplares similares